These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2550689)

  • 1. Varicella-zoster virus prevalence in Japan: no significant change in a decade.
    Taylor-Wiedeman J; Yamashita K; Miyamura K; Yamazaki S
    Jpn J Med Sci Biol; 1989 Feb; 42(1):1-11. PubMed ID: 2550689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A seroepidemiologic survey of the prevalence of varicella-zoster virus in the pediatric population in two university hospitals in Brazil.
    Semenovitch I; Lupi O
    Int J Dermatol; 2003 Mar; 42(3):193-6. PubMed ID: 12653913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of Varicella zoster virus ELISA for oral fluid suitable for epidemiological studies.
    Talukder Y; Gopal R; Andrews N; Glenn M; Breuer J; Brown D
    J Virol Methods; 2005 Sep; 128(1-2):162-7. PubMed ID: 15961168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of anti-varicella zoster IgG antibody in undergraduate students.
    Bhattarakosol P; Chantarabul S; Pittayathikhun K; Mung-mee V; Punnarugsa V
    Asian Pac J Allergy Immunol; 1996 Dec; 14(2):129-31. PubMed ID: 9177828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
    Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
    BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A laboratory study of age-related varicella incidence and prevalence in the Czech Socialist Republic.
    Trlifajová J; Svandová E; Pokorný J; Pokorný J
    Acta Virol; 1989 Mar; 33(2):183-7. PubMed ID: 2569816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of varicella-zoster virus in Korea.
    Choi WS; Noh JY; Huh JY; Jo YM; Lee J; Song JY; Kim WJ; Cheong HJ
    J Med Virol; 2010 Dec; 82(12):2123-6. PubMed ID: 20981803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroepidemiology of varicella-zoster virus in Korea.
    Lee H; Cho HK; Kim KH
    J Korean Med Sci; 2013 Feb; 28(2):195-9. PubMed ID: 23400233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of varicella-zoster virus in Polish population.
    Siennicka J; Trzcińska A; Rosińska M; Litwińska B
    Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study.
    Vandersmissen G; Moens G; Vranckx R; de Schryver A; Jacques P
    Occup Environ Med; 2000 Sep; 57(9):621-6. PubMed ID: 10935943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of IgG varicella zoster virus antibodies in the Kuikuro and Kaiabi indigenous communities in Xingu National Park, Brazil, before varicella vaccination.
    Lafer MM; de Moraes-Pinto MI; Weckx LY
    Rev Inst Med Trop Sao Paulo; 2005; 47(3):139-42. PubMed ID: 16021286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody to early antigens of varicella-zoster virus during varicella and zoster.
    Gerna G; Cereda PM; Cattaneo E; Achilli G; Gerna MT
    J Infect Dis; 1979 Jul; 140(1):33-41. PubMed ID: 88490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity.
    Heininger U; Braun-Fahrländer C; Desgrandchamps D; Glaus J; Grize L; Wutzler P; Schaad UB;
    Pediatr Infect Dis J; 2001 Aug; 20(8):775-8. PubMed ID: 11734740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-capture enzyme-linked immunosorbent assays that use enzyme-labelled antigen for detection of virus-specific immunoglobulin M, A and G in patients with varicella or herpes zoster.
    van Loon AM; van der Logt JT; Heessen FW; Heeren MC; Zoll J
    Epidemiol Infect; 1992 Feb; 108(1):165-74. PubMed ID: 1312479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.
    Wrensch M; Weinberg A; Wiencke J; Miike R; Sison J; Wiemels J; Barger G; DeLorenze G; Aldape K; Kelsey K
    Am J Epidemiol; 2005 May; 161(10):929-38. PubMed ID: 15870157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium).
    Thiry N; Beutels P; Shkedy Z; Vranckx R; Vandermeulen C; Wielen MV; Damme PV
    Eur J Pediatr; 2002 Nov; 161(11):588-93. PubMed ID: 12424583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Varicella-zoster virus seroprevalence in children between 0-15 years old].
    Savaş S; Dallar Y; Arikan I; Onde U
    Mikrobiyol Bul; 2004; 38(1-2):69-75. PubMed ID: 15293904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of antibodies to varicella-zoster virus by immune adherence hemagglutination.
    Wong CL; Castriciano S; Chernesky MA; Rawls WE
    J Clin Microbiol; 1978 Jan; 7(1):6-11. PubMed ID: 203604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of antibodies to varicella-zoster virus in Madrid (Spain) in the absence of vaccination.
    Perez-Farinos N; Garcia-Comas L; Ramirez-Fernandez R; Sanz JC; Barranco D; Garcia-Fernandez C; Ordobas M
    Cent Eur J Public Health; 2008 Mar; 16(1):41-4. PubMed ID: 18459480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of varicella-zoster antibody by immune adherence hemagglutination test.
    Kositanont U; Suvatte V; Wasi C; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):342-7. PubMed ID: 6098021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.